Cutaneous pseudolymphoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:451607L98.6
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cutaneous pseudolymphoma, also known as skin pseudolymphoma or lymphocytoma cutis, is a benign (non-cancerous) condition where the skin develops growths or patches that look very similar to lymphoma (a type of skin cancer) under the microscope, but are not actually cancer. The condition occurs when immune cells, particularly lymphocytes, build up in the skin in response to various triggers. These triggers can include insect bites, tattoos, certain medications (such as anticonvulsants, antidepressants, or antihistamines), infections like Borrelia (the bacteria that causes Lyme disease), vaccinations, or contact with foreign materials. In many cases, no clear cause is found. The condition typically appears as one or more reddish, purplish, or skin-colored bumps or nodules on the skin. These lesions are usually painless and can appear anywhere on the body, though the face, chest, and arms are common locations. The growths may be single or multiple and can sometimes be mistaken for true lymphoma, making accurate diagnosis very important. Treatment depends on identifying and removing the underlying trigger when possible. Options include topical or injected corticosteroids, surgical removal, cryotherapy (freezing), radiation therapy for stubborn lesions, or simply monitoring the condition over time. The outlook is generally very good, as cutaneous pseudolymphoma is benign and often resolves on its own once the triggering factor is removed. However, long-term follow-up is recommended because, in rare cases, the condition can persist or recur, and it is important to rule out progression to true lymphoma.

Key symptoms:

Reddish or purplish skin bumps or nodulesSkin-colored raised lumpsSingle or multiple skin lesionsPainless skin growthsLesions on the face, ears, chest, or armsSkin patches that may look like a rashSwollen-looking areas of skinLesions that may slowly grow over weeks to monthsItching at the site of the lesion (sometimes)Skin changes at the site of a previous insect bite, tattoo, or injection

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Cutaneous pseudolymphoma.

View clinical trials →

No actively recruiting trials found for Cutaneous pseudolymphoma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Cutaneous pseudolymphoma community →

No specialists are currently listed for Cutaneous pseudolymphoma.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cutaneous pseudolymphoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cutaneous pseudolymphomaForum →

No community posts yet. Be the first to share your experience with Cutaneous pseudolymphoma.

Start the conversation →

Latest news about Cutaneous pseudolymphoma

No recent news articles for Cutaneous pseudolymphoma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Could a medication or exposure be causing my skin lesions?,How confident are you that this is pseudolymphoma and not true lymphoma?,What tests were done on my biopsy to rule out cancer?,What treatment options do you recommend for my specific case?,How often should I come back for follow-up visits?,What signs should I watch for that might suggest the condition is changing or worsening?,Should I be tested for Lyme disease or other infections?

Common questions about Cutaneous pseudolymphoma

What is Cutaneous pseudolymphoma?

Cutaneous pseudolymphoma, also known as skin pseudolymphoma or lymphocytoma cutis, is a benign (non-cancerous) condition where the skin develops growths or patches that look very similar to lymphoma (a type of skin cancer) under the microscope, but are not actually cancer. The condition occurs when immune cells, particularly lymphocytes, build up in the skin in response to various triggers. These triggers can include insect bites, tattoos, certain medications (such as anticonvulsants, antidepressants, or antihistamines), infections like Borrelia (the bacteria that causes Lyme disease), vaccina

How is Cutaneous pseudolymphoma inherited?

Cutaneous pseudolymphoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Cutaneous pseudolymphoma typically begin?

Typical onset of Cutaneous pseudolymphoma is adult. Age of onset can vary across affected individuals.